Prediction model of no-response before the first transarterial chemoembolization for hepatocellular carcinoma: TACF score

Previous clinic models for patients with hepatocellular carcinoma (HCC) receiving transarterial chemoembolization (TACE) mainly focused on the overall survival, whereas a simple-to-use tool for predicting the response to the first TACE and the management of risk classification before TACE are lackin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Jia-Wei, Nie, Dan-Dan, Huang, Ji-Lan, Luo, Rong-Guang, Cheng, Qing-He, Du, Qiao-Ting, Guo, Gui-Hai, Bai, Liang-Liang, Guo, Xue-Yun, Chen, Yan, Chen, Si-Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581972/
https://www.ncbi.nlm.nih.gov/pubmed/37847433
http://dx.doi.org/10.1007/s12672-023-00803-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581972/
https://www.ncbi.nlm.nih.gov/pubmed/37847433
http://dx.doi.org/10.1007/s12672-023-00803-2

Ejemplares similares